These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6744035)

  • 21. The effect of some new aminopyridines on mammalian non-myelinated nerve fibres.
    Den Hertog A; Pielkenrood J; Biessels P; Agoston S
    Eur J Pharmacol; 1983 Oct; 94(3-4):353-5. PubMed ID: 6653665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma and cerebrospinal fluid concentrations of 4-aminopyridine following intravenous injection and metered intrathecal delivery in canines.
    Pratt K; Toombs JP; Widmer WR; Borgens RB
    J Neurotrauma; 1995 Feb; 12(1):23-39. PubMed ID: 7783231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antagonism of ethanol-induced depressant effects by 4-aminopyridine in the central nervous system of the rat.
    Sellin LC; Laakso PS
    Neuropharmacology; 1987 Apr; 26(4):385-90. PubMed ID: 3035417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ineffectiveness of 3,4-diaminopyridine as a therapy for type C botulism.
    Siegel LS; Price JI
    Toxicon; 1987; 25(9):1015-8. PubMed ID: 3433299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of 2,4-diaminopyridine with cholinesterase inhibitors.
    Biessels PT; Houwertjes MC; Agoston S; Horn AS
    Arch Int Pharmacodyn Ther; 1988; 293():228-35. PubMed ID: 3421780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminopyridine block of transient potassium current.
    Thompson S
    J Gen Physiol; 1982 Jul; 80(1):1-18. PubMed ID: 6288835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of 4-aminopyridine on cat blood pressure in relation to the sympathetic nervous system.
    Yen MH; Lee SH; Ho ST
    Eur J Pharmacol; 1985 Jul; 113(1):61-7. PubMed ID: 2995060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of 4-aminopyridine on micturition reflex in normal or capsaicin-desensitized rats.
    Maggi CA; Santicioli P; Borsini F; Giuliani S; Conte B; Lecci A; Meli A
    Brain Res; 1988 May; 449(1-2):61-70. PubMed ID: 2840174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The current status of studies of aminopyridines in patients with multiple sclerosis.
    Bever CT
    Ann Neurol; 1994; 36 Suppl():S118-21. PubMed ID: 8017870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of 3,4-diaminopyridine in human plasma by high-performance liquid chromatography.
    Kamali F; Nicholson E
    J Pharm Biomed Anal; 1995 May; 13(6):791-4. PubMed ID: 7669834
    [No Abstract]   [Full Text] [Related]  

  • 31. Synaptosomal calcium metabolism during hypoxia and 3,4-diaminopyridine treatment.
    Peterson C; Gibson GE
    J Neurochem; 1984 Jan; 42(1):248-53. PubMed ID: 6689690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis.
    Polman CH; Bertelsmann FW; de Waal R; van Diemen HA; Uitdehaag BM; van Loenen AC; Koetsier JC
    Arch Neurol; 1994 Nov; 51(11):1136-9. PubMed ID: 7980110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminopyridines for symptomatic treatment in multiple sclerosis.
    Solari A; Uitdehaag B; Giuliani G; Pucci E; Taus C
    Cochrane Database Syst Rev; 2001; 2002(4):CD001330. PubMed ID: 11687106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Aminopyridine affects synaptosomal protein phosphorylation in rat hippocampal slices.
    De Graan PN; Schrama LH; Brussaard AB; Jork R; Gispen WH
    Brain Res; 1987 Feb; 404(1-2):345-9. PubMed ID: 3032338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid-chromatographic determination of 4-aminopyridine in serum, saliva, and urine.
    Uges DR; Bouma P
    Clin Chem; 1981 Mar; 27(3):437-40. PubMed ID: 7471395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of aminopyridines in neurological disorders.
    Sedehizadeh S; Keogh M; Maddison P
    Clin Neuropharmacol; 2012; 35(4):191-200. PubMed ID: 22805230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood-brain barrier dysfunction can contribute to pharmacoresistance of seizures.
    Salar S; Maslarova A; Lippmann K; Nichtweiss J; Weissberg I; Sheintuch L; Kunz WS; Shorer Z; Friedman A; Heinemann U
    Epilepsia; 2014 Aug; 55(8):1255-63. PubMed ID: 24995798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 4-aminopyridine in experimental CNS demyelination.
    Kaji R; Sumner AJ
    Neurology; 1988 Dec; 38(12):1884-7. PubMed ID: 2848207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neocortical cytopathology in focal aminopyridine seizures as related to the intracortical diffusion of [3H] 4-aminopyridine. Electrophysiologic and light-microscopic studies.
    Mihály A; Tóth G; Szente M; Joó F
    Acta Neuropathol; 1985; 66(2):145-54. PubMed ID: 2990141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3,4-Diaminopyridine partially reverses phospholipid breakdown induced by oxygen deprivation of cultured myocardial cells.
    Freyss-Béguin M; Millanvoye-Van Brussel E; Griffaton G; Lechat P
    Biochem Pharmacol; 1986 Jun; 35(11):1915-8. PubMed ID: 3718536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.